Sustainability remains a key priority
"We are committed to reach net zero emissions across the value chain by 2050".
5.3.2026
We believe a sustainable future starts with health. Sustainability is embedded in our strategy and everyday practices. Our sustainability agenda drives our actions forward towards our ambitious long-term goals. We updated the agenda in 2025, for instance to include our new climate targets. "We are committed to reach net zero emissions across the value chain by 2050" - Katarina Gabrielson, CEO
New ambitious climate targets validated by the SBTi
In 2025, our new ambitious climate targets were validated by the Science Based Targets initiative (SBTi), confirming alignment with the 1.5°C pathway.
We are proud of our commitment to reach net-zero greenhouse gas emissions across the value chain by 2050. Achieving alignment of climate commitments throughout the value chain is critical to reaching the net-zero target. Accordingly, we encourage our suppliers to establish science-based targets by 2028. Our near-term target is to decrease Scope 1 and 2 emissions by 67% by 2030 from a 2023 base year. Compared with the base year, we have reduced Scope 1 and Scope 2 emissions by 40%.
Oriola is part of the critical infrastructure
Safeguarding deliveries of pharmaceuticals is a central part of our social responsibility and our role in the healthcare value chain. To ensure that we fulfil our promise, we closely monitor the picking accuracy of our deliveries, which in 2025 reached 99.8%, well above our target.
We also work actively with authorities and other relevant actors to strengthen pharmaceutical preparedness. During last year, we participated in dialogues and meetings with Swedish authorities and cross-sector forums, where we represent the distributor perspective. This work is particularly important in Sweden, where the system for pharmaceutical preparedness is still under development. Our extensive experience from the Finnish preparedness framework provides valuable insights that we can use to support progress and resilience.
Finland advanced the deregulation of its pharmacy market in 2025 through a government working group proposal enabling the controlled sale of selected overthecounter medicines outside traditional pharmacies. Further legislative preparation continues in a working group, which is examining additional reforms to modernise the sector and ensure medication safety remains central to the evolving regulatory framework.
Advancing leadership during periods of change
Advancing a culture that ensures fairness, develops capable individuals, and empowers leaders, is particularly crucial during periods of change. In 2025, we completed the renewal of our operating model, and our leadership index reached a score of 75. Ensuring a common understanding and fostering a culture of doing the right thing is important for us. Part of this is to ensure that employees complete Code of Conduct training. In 2025, we measured this for the first time and reached a completion rate of 72%.
Sustainability efforts recognised
In 2025, we retained the EcoVadis gold medal for the third consecutive year, which reflects strong performance in environmental and ethical business practices. This strengthens our position in stakeholder dialogues and supports transparency in climate reporting.
We are committed to sustainability as a longterm strategic focus area. Our sustainability agenda with its ambitious targets, establishes clear priorities for our on-going sustainability efforts. Working together across Oriola and partnering closely throughout the value chain, we can strengthen our impact and advance a healthier future.
Katarina Gabrielson is Oriola’s CEO. This text is based on Oriola’s Annual Report 2025 published on 4 March 2026.
Oriola’s Annual Report includes the business review, sustainability statement and financial statements. The Sustainability statement has been prepared in accordance with the European Sustainability Reporting Standards (ESRS) and covers the following standards: ESRS2, E1, E5, S1, S4 and G1. The Sustainability statement has been assured (limited assurance).